Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.754 Million Vs. IBES Estimate USD 24.6 Million
25/06/2025 23:16
Jun 25 (Reuters) - Medexus Pharmaceuticals Q4 net income USD -553 thousand. Q4 adjusted EBITDA USD 2.265 million
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million